Healthcare Market News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 72,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "0a188514-10d3-49ec-8912-055e9867410f",
"title": "Bayer Stock: Is This The Turning Point Investors Have Been Waiting For? (OTCMKTS:BAYZF)",
"description": "Bayer stock may offer upside despite litigation and debt risks. Learn how recent developments could unlock value for BAYZF stock.",
"keywords": "",
"snippet": "It only had been about two months since I published my last article about the German pharmaceutical and life-science company Bayer Aktiengesellschaft ( BAYZF )....",
"url": "https://seekingalpha.com/article/4853140-bayer-stock-is-this-the-turning-point-investors-have-been-waiting-for",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/96224497/image_96224497.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-12-13T10:05:40.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "BAY.MI",
"name": "Bayer Aktiengesellschaft",
"exchange": null,
"exchange_long": null,
"country": "it",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.570663,
"sentiment_score": 0,
"highlights": [
{
"highlight": "It only had been about two months since [+138 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYRY",
"name": "Bayer Aktiengesellschaft",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.57054,
"sentiment_score": 0,
"highlights": [
{
"highlight": "It only had been about two months since [+138 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYZF",
"name": "Bayer Aktiengesellschaft",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.21238,
"sentiment_score": 0.31245,
"highlights": [
{
"highlight": "It only had been about two months since [+147 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Analyst’s Disclosure:I/we have a benef[+249 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "fca1e5a4-17b1-4a3f-9cf2-bf8c1f481fc9",
"title": "MIST Hits A Milestone: FDA Approves First-Ever Self-Administered Nasal Spray For PSVT",
"description": "Milestone Pharmaceuticals Inc. (MIST) has received FDA approval for its first commercial product, CARDAMYST nasal spray, for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia to sinus rhythm in adults.",
"keywords": "FDA approval, Nasal Spray, PSVT, MIST",
"snippet": "Milestone Pharmaceuticals Inc. (MIST) has received for its first commercial product, CARDAMYST nasal spray, for the conversion of acute symptomatic episodes of ...",
"url": "https://www.rttnews.com/story.aspx?Id=3603584",
"image_url": "https://cdn.rttnews.com/images/v4/RTTNews-logo-512x512.png",
"language": "en",
"published_at": "2025-12-13T06:25:36.000000Z",
"source": "rttnews.com",
"relevance_score": null,
"entities": [
{
"symbol": "MIST",
"name": "Milestone Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 33.76042,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Milestone</em> <em>Pharmaceuticals</[+213 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "cf5f0455-4f27-4370-bc87-a10476f190e6",
"title": "Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)",
"description": "First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythmFDA approval in PSVT enables development of AFib-RVR under sNDA pathwayMilestone well-capitalized to launch and commercialize CARDAMYST with existing capital and royalty financingConference call and webcast December 15, 8:00 a.m. ET MONTREAL and CHARLOTTE, N.C., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that the U.S. Food and Drug Administration (FDA) approved its first commercial product, CARDAMYST™ (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. This approval marks the first time that more than two million Americans with PSVT will have a rapid-acting treatment option they can self-administer outside the emergency department or other healthcare setting. CARDAMYST is expected to be available in retail pharmacies in the first quarter of 2026.",
"keywords": "Milestone, Receives, FDA, Approval, of, CARDAMYST™, (etripamil), as, First, and, Only, Self-Administered, Nasal, Spray, for, Adults, with, Paroxysmal, Supraventricular, Tachycardia, (PSVT)",
"snippet": "First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT\n\nNovel nasal spray designed to rapidly resolve episodes of PSVT and restor...",
"url": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/milestone-receives-fda-approval-of-cardamyst-etripamil-as-first-and-only-self-administered-nasal-spray-for-adults-with-paroxysmal-supraventricular-tachycardia-psvt/2242773",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/13/865939.png",
"language": "en",
"published_at": "2025-12-13T01:06:23.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "MIST",
"name": "Milestone Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 26.17947,
"sentiment_score": 0.694533,
"highlights": [
{
"highlight": "(<em>Nasdaq</em>: <em>MIST</em>) today a[+286 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "\"CARDAMYST is a novel at-the-ready treat[+243 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Milestone</em> <em>Pharmaceuti[+255 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "2648ed09-abe8-4de6-91d4-c5e1440ba4de",
"title": "Ferrovial consigue entrar al selectivo estadounidense Nasdaq 100",
"description": "La empresa española Ferrovial ha logrado entrar este viernes en el Nasdaq 100 y convertirse en una de las 100 mayores empresas no financieras",
"keywords": "",
"snippet": "La empresa española Ferrovial ha logrado entrar este viernes en el Nasdaq 100 y convertirse en una de las 100 mayores empresas no financieras del índice burs?...",
"url": "https://forbes.es/economia/845540/ferrovial-consigue-entrar-al-selectivo-estadounidense-nasdaq-100/",
"image_url": "https://forbes.es/wp-content/uploads/2025/12/fotonoticia_20251213063010_1920-1200x675.jpg",
"language": "es",
"published_at": "2025-12-13T06:05:02.000000Z",
"source": "forbes.es",
"relevance_score": null,
"entities": [
{
"symbol": "ALNY",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.894714,
"sentiment_score": null,
"highlights": [
{
"highlight": "Las empresas incluidas en esta renovaci?[+321 characters]",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BIIB",
"name": "Biogen Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.831062,
"sentiment_score": null,
"highlights": [
{
"highlight": "Por el contrario, ha abandonado el selec[+123 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "INSM",
"name": "Insmed Incorporated",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.18091,
"sentiment_score": null,
"highlights": [
{
"highlight": "Las empresas incluidas en esta renovaci?[+321 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c411613d-15de-4a61-8b80-61044203d4fd",
"title": "Trump’s Market Mayhem: A Daily Dose of Volatility",
"description": "Ah, the stock market. A bastion of rational exuberance, they say. Or, perhaps, a highly sensitive barometer of geopolitical whims, presidential",
"keywords": "",
"snippet": "Ah, the stock market. A bastion of rational exuberance, they say. Or, perhaps, a highly sensitive barometer of geopolitical whims, presidential pronouncements, ...",
"url": "https://stockmarketwatch.com/stock-market-news/trumps-market-mayhem-a-daily-dose-of-volatility-3/57139/",
"image_url": "https://stockmarketwatch.com/stock-market-news/wp-content/uploads/2025/07/smw-icon-1000x700-logo.png",
"language": "en",
"published_at": "2025-12-13T06:01:04.000000Z",
"source": "thestockmarketwatch.com",
"relevance_score": null,
"entities": [
{
"symbol": "APHA",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.304544,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "In a rare moment of bipartisan joy, cann[+288 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TLRY",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.304554,
"sentiment_score": 0.872,
"highlights": [
{
"highlight": "In a rare moment of bipartisan joy, cann[+288 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CGC",
"name": "Canopy Growth Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.275822,
"sentiment_score": 0.8074,
"highlights": [
{
"highlight": "In a rare moment of bipartisan joy, cann[+297 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "09ee1326-cb4b-4767-9ec0-122f7ceb7cdf",
"title": "HSBC Cuts Zoetis Inc. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating",
"description": "Zoetis Inc. (NYSE:ZTS) is among the 11 Most Oversold S&P 500 Stocks Heading into 2026.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/hsbc-cuts-zoetis-inc-ztss-price-target-to-140-from-180-keeps-buy-rating-1659445/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/15085306/PHT-insidermonkey-1702648383866.jpg",
"language": "en",
"published_at": "2025-12-13T03:58:49.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZTS",
"name": "Zoetis Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.3087,
"sentiment_score": -0.296,
"highlights": [
{
"highlight": "HSBC Cuts <em>Zoetis</em> <em>Inc</em>. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "ZOE.DE",
"name": "Zoetis Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.3045,
"sentiment_score": -0.296,
"highlights": [
{
"highlight": "HSBC Cuts <em>Zoetis</em> <em>Inc</em>. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "ZTS.MX",
"name": "Zoetis Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.302216,
"sentiment_score": -0.296,
"highlights": [
{
"highlight": "HSBC Cuts <em>Zoetis</em> <em>Inc</em>. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "Z1TS34.SA",
"name": "Zoetis Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.29376,
"sentiment_score": -0.296,
"highlights": [
{
"highlight": "HSBC Cuts <em>Zoetis</em> <em>Inc</em>. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "cfda58e9-7c1b-4128-811f-9277e44bb72b",
"title": "Johnson & Johnson ordered to pay $40 million to two women in latest talc trial",
"description": "Johnson & Johnson ordered to pay $40 million for talc-related ovarian cancer, with plans to appeal the jury's verdict.",
"keywords": "",
"snippet": "A California jury in the U.S. on Friday (December 12, 2025) awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their o...",
"url": "https://www.thehindu.com/business/Industry/johnson-johnson-ordered-to-pay-40-million-to-two-women-in-latest-talc-trial/article70391440.ece",
"image_url": "https://th-i.thgim.com/public/incoming/mmdecg/article70391444.ece/alternates/LANDSCAPE_1200/2025-10-07T151240Z_8809158_RC227HAJFMBO_RTRMADP_3_J-J-TALC-VERDICT.JPG",
"language": "en",
"published_at": "2025-12-13T03:03:51.000000Z",
"source": "thehindu.com",
"relevance_score": null,
"entities": [
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.908356,
"sentiment_score": -0.44225,
"highlights": [
{
"highlight": "The jury in Los Angeles Superior Court a[+223 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "In closing arguments that Reuters viewed[+327 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "No evidence, says company\n\nAllison Brown[+100 characters]",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Johnson</em> & <em>Johnson</em> ordered to pay $40 million to two women in latest talc trial",
"sentiment": -0.1027,
"highlighted_in": "title"
}
]
},
{
"symbol": "DJNJ2.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.90213,
"sentiment_score": -0.44225,
"highlights": [
{
"highlight": "The jury in Los Angeles Superior Court a[+223 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "In closing arguments that Reuters viewed[+327 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "No evidence, says company\n\nAllison Brown[+100 characters]",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Johnson</em> & <em>Johnson</em> ordered to pay $40 million to two women in latest talc trial",
"sentiment": -0.1027,
"highlighted_in": "title"
}
]
},
{
"symbol": "DJNJ3.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.90213,
"sentiment_score": -0.44225,
"highlights": [
{
"highlight": "The jury in Los Angeles Superior Court a[+223 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "In closing arguments that Reuters viewed[+327 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "No evidence, says company\n\nAllison Brown[+100 characters]",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Johnson</em> & <em>Johnson</em> ordered to pay $40 million to two women in latest talc trial",
"sentiment": -0.1027,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "f3b11c18-c91b-463a-873c-3b34db26a958",
"title": "Annual Changes to the Nasdaq-100 Index®",
"description": "NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.",
"keywords": "Annual, Changes, to, the, Nasdaq-100, Index®",
"snippet": "NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), wh...",
"url": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/annual-changes-to-the-nasdaq-100-index/2242771",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/13/865938.jpg",
"language": "en",
"published_at": "2025-12-13T01:06:11.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "ALNY",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 84.19694,
"sentiment_score": 0.255,
"highlights": [
{
"highlight": "The following six companies will be adde[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "delivered to your inbox Sign up for The [+325 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+328 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BIIB",
"name": "Biogen Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 55.906815,
"sentiment_score": 0,
"highlights": [
{
"highlight": "As a result of the reconstitution, the f[+305 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "INSM",
"name": "Insmed Incorporated",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 82.37379,
"sentiment_score": 0.4633,
"highlights": [
{
"highlight": "(Nasdaq: ALNY), Ferrovial SE (Nasdaq: FE[+206 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": ", I acknowledge that I have read and agr[+325 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Incorporated</em> - https://insmed.c[+288 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BIIB.MX",
"name": "Biogen Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.755379,
"sentiment_score": 0,
"highlights": [
{
"highlight": "As a result of the reconstitution, the f[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "A1LN34.SA",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 45.90784,
"sentiment_score": 0.255,
"highlights": [
{
"highlight": "The following six companies will be adde[+283 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "delivered to your inbox Sign up for The [+325 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+328 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BIIB.BA",
"name": "Biogen Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.756556,
"sentiment_score": 0,
"highlights": [
{
"highlight": "As a result of the reconstitution, the f[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IDP.DE",
"name": "Biogen Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.756207,
"sentiment_score": 0,
"highlights": [
{
"highlight": "As a result of the reconstitution, the f[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DUL.DE",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 45.925747,
"sentiment_score": 0.255,
"highlights": [
{
"highlight": "The following six companies will be adde[+283 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "delivered to your inbox Sign up for The [+325 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+328 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3f2b612c-a9e1-44dd-ad89-bd3b02559460",
"title": "米国株式市場は下落 ブロードコム急落でAI・半導体関連に売り波及",
"description": "「シカゴ日経平均先物（ＣＭＥ）」（12日）。",
"keywords": "マーケット, 海外株式市場, ",
"snippet": "*09:43JST 米国株式市場は下落 ブロードコム急落でAI・半導体関連に売り波及\n\n「シカゴ日経平均先物（ＣＭＥ）」（12日?...",
"url": "https://www.zaikei.co.jp/article/20251213/836206.html",
"image_url": "http://www.zaikei.co.jp/images/zaikei_og_image.jpg",
"language": "ja",
"published_at": "2025-12-13T00:43:15.000000Z",
"source": "zaikei.co.jp",
"relevance_score": null,
"entities": [
{
"symbol": "HOCPY",
"name": "HOYA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 12.378784,
"sentiment_score": null,
"highlights": [
{
"highlight": "4\n\n7267 (HMC.N) 本田技研工業 30.93[+410 characters]",
"sentiment": null,
"highlighted_in": "main_text"
},
{
"highlight": ") <em>HOYA</em> 151.44 -2.04 23552 -34\n\n[+385 characters]",
"sentiment": null,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "8c6cd408-afc6-403d-b1f5-33a0f19732b2",
"title": "Genesis Healthcare Remains Committed to Securing Longterm Stability",
"description": "The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process centered around current and future patients, residents and staff",
"keywords": "Genesis, Healthcare, Remains, Committed, to, Securing, Longterm, Stability",
"snippet": "The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process centered around current and future patients,...",
"url": "https://www.manilatimes.net/2025/12/13/tmt-newswire/globenewswire/genesis-healthcare-remains-committed-to-securing-longterm-stability/2242761",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/13/865927.jpg",
"language": "en",
"published_at": "2025-12-12T23:25:40.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "GEN",
"name": "Genesis Healthcare, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 82.95287,
"sentiment_score": 0.474729,
"highlights": [
{
"highlight": "., Dec. 11 to reopen the auction process[+345 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Get the latest news\n\ndelivered to your i[+333 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "favorable rating for relationship with s[+334 characters]",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>GENESIS</em> <em>HEALTHCARE</e[+187 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Its subsidiaries also specialize in cont[+257 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Genesis</em> <em>Healthcare</em> Remains Committed to Securing Longterm Stability",
"sentiment": 0.5267,
"highlighted_in": "title"
}
]
},
{
"symbol": "GENN",
"name": "Genesis Healthcare, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 82.95154,
"sentiment_score": 0.474729,
"highlights": [
{
"highlight": "., Dec. 11 to reopen the auction process[+345 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Get the latest news\n\ndelivered to your i[+333 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "favorable rating for relationship with s[+334 characters]",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Healthcare</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ABOUT <em>GENESIS</em> <em>HEALTHCARE</e[+187 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Its subsidiaries also specialize in cont[+257 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Genesis</em> <em>Healthcare</em> Remains Committed to Securing Longterm Stability",
"sentiment": 0.5267,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5bba0bde-1ab2-4e4a-81c1-49f8e1457897",
"title": "Xenon Pharmaceuticals Inc. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation - Slideshow (NASDAQ:XENE) 2025-12-12",
"description": "2025-12-12. The following slide deck was published by Xenon Pharmaceuticals Inc.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/article/4853077-xenon-pharmaceuticals-inc-xene-discusses-latest-phase-iii-updates-for-azetukalner-in-epilepsy",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-12-12T23:14:18.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "XENE",
"name": "Xenon Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 133.93362,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Xenon</em> <em>Pharmaceuticals</em> <em>Inc</em>. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation - Slideshow (<em>NASDAQ:XENE</em>) 2025-12-12",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "Healthcare",
"total_documents": 178,
"sentiment_avg": 0.31614822660421216
}
]
}
Other details
Entity count
- 11,338